SUREPAL Trademark

Trademark Overview

On Friday, August 17, 2018, a trademark application was filed for SUREPAL with the United States Patent and Trademark Office. The USPTO has given the SUREPAL trademark a serial number of 88083334. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 12, 2025. This trademark is owned by Novartis AG. The SUREPAL trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceutical preparations
surepal

General Information

Serial Number88083334
Word MarkSUREPAL
Filing DateFriday, August 17, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 12, 2025
Registration Number5761410
Registration DateTuesday, May 28, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 29, 2019

Trademark Statements

Goods and ServicesInjection device for pharmaceutical preparations
Pseudo MarkSURE PAL

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 12, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANDOZ AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBASEL 4051
CH
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, August 21, 2018NEW APPLICATION ENTERED
Monday, August 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 24, 2018ASSIGNED TO EXAMINER
Thursday, September 27, 2018SUSPENSION LETTER WRITTEN
Thursday, September 27, 2018LETTER OF SUSPENSION E-MAILED
Thursday, September 27, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 11, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 17, 2018ASSIGNED TO LIE
Wednesday, December 19, 2018ASSIGNED TO LIE
Thursday, December 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 29, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 28, 2019TEAS DELETE 1(B) BASIS RECEIVED
Friday, April 19, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 28, 2019NOTICE OF ALLOWANCE CANCELLED
Friday, April 19, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 12, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

surepal preparations pharmaceutical device injection